Adina Devendra Amin

Adina Amin practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Adina Amin's NPI, 1760068647, was assigned on March 22, 2021. Adina Amin holds Connecticut license 79049.

Adina Amin's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Adina Amin's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Adina Amin is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Adina Amin to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Adina Amin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Adina Amin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Adina Amin is licensed in Connecticut.

CMS data shows 105 Medicare services from Adina Amin across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $7,751 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Adina Amin in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adina Amin's median patient age at 66, with 50% women.

In 2024, Adina Amin wrote 157 Medicare Part D claims for 39 patients. 88% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $307 in total drug cost. In 2023, CMS named 71 claims across 5 drugs.

Adina Amin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Adina Amin from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $491.